The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy
The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.
World-renowned experts from leading cancer centers are at the forefront of our research.
Our model allows us to work with top talent across disciplines beyond our six centers.
Open in Twitter Parker Institute @parkerici RT @PennMedNews: .@parkerici will evaluate combinations of immunotherapies with chemotherapy to treat pancreatic cancer: https://t.co/Kss8I… 24 hours ago
Open in Twitter Parker Institute @parkerici RT @EricTopol: Is CAR-T cell therapy like a Model T car? https://t.co/sc3AzOc7AK @CellCellPress @CellPressNews Well done by @HelenaXiaoho… 3 days ago